HomeExpertisePostersChinaBio 2026, Shanghai, ChinaOptimization of step-up dosing regimen of T-cell engagers to mitigate cytokine release syndrome using quantitative systems pharmacology modeling: tarlatamab case study
We use cookies (and other similar technologies) to collect data to improve your experience on our site.
By using our website, you agree to data collection as described in our website’s data collection policy.
